Sapience Therapeutics IPO

Sapience Therapeutics develops peptide-based oncology treatments and therapies by targeting intracellular interactions.

Register for Details

For more details on financing and valuation for Sapience Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Sapience Therapeutics's ticker symbol?

Sapience Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Sapience Therapeutics's stock price?

The stock price for Sapience Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Sapience Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
5/31/2022 Series B and B-1 $289.73MM $XXX.XX $XXX.XX
7/12/2016 Series A $76.28MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Sapience Therapeutics

What is Sapience Therapeutics funding to date?

Sapience Therapeutics has raised $63.88MM with the following series:
$76.28MM for Series A, $289.73MM for Series B and B-1

When was Sapience Therapeutics founded?

Sapience Therapeutics was founded in 2015.

Can you invest in Sapience Therapeutics?

Sapience Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Sapience Therapeutics share pre-IPO?

If you own Sapience Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is Sapience Therapeutics a publicly traded company?

Sapience Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Sapience Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector
 
 
Sector
Last Round Est. Valuation
$500MM